We've found
7,522
archived clinical trials in
Chronic Pain
We've found
7,522
archived clinical trials in
Chronic Pain
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
A 12-Week Efficacy Study of Paracetamol 1000mg Sustained-release Tablets in Patients With Osteoarthritis
Updated: 4/18/2016
An Efficacy and Safety Study of Sustained-release Paracetamol in Subjects With Osteoarthritis
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
Updated: 4/18/2016
RC11C3, Pilot Placebo-Controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
Status: Enrolling
Updated: 4/18/2016
Pregabalin in Preventing Acute Pain Syndrome in Patients Receiving Paclitaxel
Updated: 4/18/2016
RC11C3, Pilot Placebo-Controlled Evaluation of Pregabalin as a Means to Prevent the Paclitaxel-Associated Acute Pain Syndrome
Status: Enrolling
Updated: 4/18/2016
Click here to add this to my saved trials
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Updated: 4/20/2016
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Status: Enrolling
Updated: 4/20/2016
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Updated: 4/20/2016
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Status: Enrolling
Updated: 4/20/2016
Click here to add this to my saved trials
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Updated: 4/20/2016
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Status: Enrolling
Updated: 4/20/2016
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Updated: 4/20/2016
Refining Paracervical Block Techniques for Pain Control in First Trimester Surgical Abortion
Status: Enrolling
Updated: 4/20/2016
Click here to add this to my saved trials
Effects of a Patient Driven Assessment Process With Complex Pain Patients
Updated: 4/20/2016
Effects of a Patient Driven Assessment Process With Complex Pain Patients (PDAP)
Status: Enrolling
Updated: 4/20/2016
Effects of a Patient Driven Assessment Process With Complex Pain Patients
Updated: 4/20/2016
Effects of a Patient Driven Assessment Process With Complex Pain Patients (PDAP)
Status: Enrolling
Updated: 4/20/2016
Click here to add this to my saved trials
Ear Acupuncture for Pain Associated With Ambulatory Arthroscopic Knee Surgery
Updated: 5/2/2016
Ear Acupuncture for Post-operative Pain Associated With Ambulatory Arthroscopic Knee Surgery - A Randomized Controlled Trial
Status: Enrolling
Updated: 5/2/2016
Ear Acupuncture for Pain Associated With Ambulatory Arthroscopic Knee Surgery
Updated: 5/2/2016
Ear Acupuncture for Post-operative Pain Associated With Ambulatory Arthroscopic Knee Surgery - A Randomized Controlled Trial
Status: Enrolling
Updated: 5/2/2016
Click here to add this to my saved trials
Bupivacaine Injections Into Uterosacral Ligaments During Robotic Assisted Total Hysterectomies
Updated: 5/4/2016
Effectiveness of Bupivacaine With Epinephrine Injections Into the Uterosacral Ligaments for Post-operative Pain Control and the Use of Narcotic Pain Medication Following Robotic Assisted Total Hysterectomies
Status: Enrolling
Updated: 5/4/2016
Bupivacaine Injections Into Uterosacral Ligaments During Robotic Assisted Total Hysterectomies
Updated: 5/4/2016
Effectiveness of Bupivacaine With Epinephrine Injections Into the Uterosacral Ligaments for Post-operative Pain Control and the Use of Narcotic Pain Medication Following Robotic Assisted Total Hysterectomies
Status: Enrolling
Updated: 5/4/2016
Click here to add this to my saved trials
Safety Study of Deep Brain Stimulation to Manage Thalamic Pain Syndrome
Updated: 5/23/2016
Deep Brain Stimulation for Thalamic Pain Syndrome
Status: Enrolling
Updated: 5/23/2016
Safety Study of Deep Brain Stimulation to Manage Thalamic Pain Syndrome
Updated: 5/23/2016
Deep Brain Stimulation for Thalamic Pain Syndrome
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
Updated: 5/23/2016
An Open-label, Multicenter Study of the Safety, Pharmacokinetics, and Efficacy of Buprenorphine Transdermal System (BTDS) in Children From 7 to 16 Years of Age, Inclusive, Who Require Continuous Opioid Analgesia for Moderate to Severe Pain
Status: Enrolling
Updated: 5/23/2016
Click here to add this to my saved trials